April 13, 2023 02:27 PM EDT
Pharma

Pfiz­er teams up with Sinopharm to mar­ket 12 new drugs in Chi­na — re­port

Katherine Lewin

News Reporter

Pfiz­er and Chi­na-based Sinopharm Group have teamed up to seek ap­proval for 12 new drugs in Chi­na through 2025, Reuters re­port­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

One Feb­ru­ary FDA ad­comm meet­ing is de­layed, an­oth­er can­celed

The RFK ques­tion: Trump's HHS nom­i­nee splits bio­phar­ma be­fore mo­ment of truth

Semaglu­tide, tirzepatide com­pounder hit with FDA warn­ing let­ter 

Ahead of earn­ings, Lil­ly culls mid-stage drug for heart fail­ure and chron­ic kid­ney dis­ease

No­vo Nordisk asks Third Cir­cuit to ex­pe­dite IRA case as par­tic­i­pa­tion dead­line looms

sponsored

Why the pre­mier re­cruit­ment agency in the world is giv­ing up re­cruit­ing, and spon­sors should, too

A service from the Financial Times